Bart A. van den Berg
Oprichter bij VenGen BV
Oorsprong van het eerstegraads netwerk van Bart A. van den Berg
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
VenGen BV
VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences.
7
| Subsidiary | Investment Managers | 7 |
Diagnoptics Technologies BV
Diagnoptics Technologies BV Medical SpecialtiesHealth Technology DiagnOptics Technologies BV develops and manufactures diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. The firm’s AGE reader diagnoses and assesses the risk of cardiovascular, diseases through measuring tissue accumulation of AGEs. The company was founded by Reindert Graaff and Andries J. Smit in 2003 and is headquartered in Groningen, the Netherlands.
5
| Holding Company | Medical Specialties | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bart A. van den Berg via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
PHARMING GROUP N.V. | Pharmaceuticals: Major | Chairman | |
Erasmus University Rotterdam | College/University | Masters Business Admin | |
University of Utrecht | College/University | Graduate Degree | |
University of Groningen | College/University | Graduate Degree Doctorate Degree | |
Vrije Universiteit Amsterdam | College/University | Graduate Degree | |
VenGen Holding BV
VenGen Holding BV Financial ConglomeratesFinance VenGen Holding BV provides investment services. The private company is based in Amsterdam, Netherlands. and has subsidiaries in Netherlands. The Dutch company was founded by Jaap Blaak. | Financial Conglomerates | Founder | |
FlexGen Holding BV
FlexGen Holding BV Medical SpecialtiesHealth Technology FlexGen Holding BV produces micro-arrays with the use of lasers in the synthesis of oligonucleotides. The company was founded in 2004 and is headquartered in Leiden, the Netherlands. | Medical Specialties | Director/Board Member | |
TAilWind BV
TAilWind BV Financial ConglomeratesFinance TAilWind BV provides financial and investment services to biotechnology companies. The company was founded by Jaap Blaak in 1995 and is headquartered in Wassenaar, Netherlands. | Financial Conglomerates | Founder | |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | Pharmaceuticals: Other | Chief Executive Officer | |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Photonics Healthcare BV
Photonics Healthcare BV Medical SpecialtiesHealth Technology Photonics Healthcare BV engages in the development of medical devices for monitoring mitochondrial function in to clinical practice. It offers Comet monitor, which allows doctors to optically measure the oxygen in the mitochondria inside a patient's cells. The company was founded by Egbert Gezinus Mik, Michael Münker, and Alfred N. Nijkerk in October 2009 and is headquartered in Utrecht, the Netherlands. | Medical Specialties | Founder | |
UbiQ Bio BV
UbiQ Bio BV Pharmaceuticals: MajorHealth Technology UbiQ Bio BV specializes in the ubiquitin related reagents, peptides and assays. The firm focuses on pharma companies and academic research labs. The company was founded by by Huib Ovaa and Farid El Oualidin in 2010 and is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
China Medical University | College/University | Doctorate Degree |
Statistieken
Internationaal
Nederland | 18 |
China | 2 |
Sectoraal
Health Technology | 10 |
Consumer Services | 6 |
Finance | 3 |
Consumer Non-Durables | 2 |
Distribution Services | 2 |
Operationeel
Founder | 11 |
Corporate Officer/Principal | 7 |
Director/Board Member | 5 |
Private Equity Investor | 4 |
Graduate Degree | 3 |
Sterkste connecties
Insiders | |
---|---|
Jaap Blaak | 10 |
Alfred N. Nijkerk | 7 |
Jibin Chi | 4 |
Jasper Dijkstra | 3 |
Michiel Kregel | 2 |
Paul West | 1 |
Robert Braakman | 1 |
Paul van Raan | 1 |
Reindert Graaff | 1 |
Andries J. Smit | 1 |
Michael Muenker | 1 |
- Beurs
- Insiders
- Bart A. van den Berg
- Bedrijfsconnecties